Moderna reported $3.55B in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Alnylam Pharmaceuticals USD 2.11B 358.58M Sep/2026
Amgen USD 51.61B 250M Sep/2026
Arrowhead Research USD 824.07M 401.34M Jun/2026
Biogen USD 7.29B 1.7M Sep/2026
BioMarin Pharmaceutical USD 3.51B 12.96M Sep/2026
Celltrion KRW 412.88B 1.61B Jun/2026
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 40M 10M Sep/2026
Gilead Sciences USD 23.82B 17M Sep/2026
GlaxoSmithKline GBP 21.7B 7.75B Sep/2026
Incyte USD 28.42M 994K Jun/2026
Ionis Pharmaceuticals USD 1.77B 140.62M Sep/2026
Kangmei Pharma CNY 67.35M 1.22M Jun/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Moderna USD 3.55B 2.95B Sep/2026
Organigram Holdings CAD 17.61M 43.15M Jun/2026
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 36.24M 4.11M Sep/2026
Puma Biotechnology USD 10.87M 222K Jun/2025
Qiagen NV USD 1.63B 19.45M Jun/2026
Regeneron Pharmaceuticals USD 1.99B 400K Sep/2026
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 699.39M 148.23M Sep/2026
Sartorius EUR 3.43B 216.6M Sep/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Tilray USD 268.59M 3.82M Sep/2025
Ultragenyx Pharmaceutical USD 1.13B 2M Jun/2026
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 3.5B 3.39B Sep/2026
Zealand Pharma A/S 307M 76.14M Mar/2026
Zz Pientze Pharmaceu CNY 160.45M 12.35M Sep/2026